BIO-TECHNE Corp Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
BIO-TECHNE Corp quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2010 to Q3 2024.
  • BIO-TECHNE Corp Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $224M, a 9.35% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $224M +$19.1M +9.35% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $241M +$22.9M +10.5% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $228M +$11.5M +5.3% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $207M +$22.7M +12.3% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $205M +$30.4M +17.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $218M +$23.9M +12.3% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $216M +$14.3M +7.09% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $185M +$31.9M +20.8% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $174M +$26.6M +18% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $195M +$49.2M +33.8% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $202M +$44.3M +28.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $153M +$24.7M +19.2% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $148M +$24.9M +20.3% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $145M +$22.9M +18.6% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $158M +$40.3M +34.3% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $128M +$16.5M +14.8% Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $123M -$89K -0.07% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $123M -$14.9M -10.9% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $117M -$16.5M -12.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $112M -$1.53M -1.35% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $123M +$7.97M +6.95% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $137M +$17.2M +14.3% Jun 30, 2019 10-K 2020-08-26
Q1 2019 $134M +$24.2M +22% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $113M +$14.8M +15% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $115M +$7.43M +6.92% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $120M +$3.47M +2.97% Jun 30, 2018 10-K/A 2019-11-06
Q1 2018 $110M -$8.58M -7.25% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $98.5M -$5.87M -5.62% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $107M -$2.49M -2.27% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $117M +$23.4M +25.1% Jun 30, 2017 10-K 2018-08-27
Q1 2017 $118M +$31.2M +35.8% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $104M +$38.2M +57.8% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $110M +$38.9M +54.9% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $93.4M +$23.4M +33.4% Jun 30, 2016 10-K 2017-09-07
Q1 2016 $87.2M +$21.3M +32.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $66.1M +$8.92M +15.6% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $70.9M +$10M +16.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $70M +$15M +27.3% Jun 30, 2015 10-K 2016-08-29
Q1 2015 $65.9M +$17.4M +35.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $57.2M +$18.9M +49.4% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $60.9M +$18.6M +44.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $55M +$16.8M +44% Jun 30, 2014 10-K 2015-08-31
Q1 2014 $48.5M +$10.4M +27.2% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $38.3M +$6.12M +19% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $42.2M +$7.12M +20.3% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $38.2M +$2.52M +7.05% Jun 30, 2013 10-K 2014-08-29
Q1 2013 $38.1M -$976K -2.5% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $32.2M -$164K -0.51% Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $35.1M +$1.03M +3.01% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $35.7M -$246K -0.69% Jun 30, 2012 10-K 2013-08-29
Q1 2012 $39.1M +$3.56M +10% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $32.4M +$4.12M +14.6% Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $34.1M +$3.07M +9.91% Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $35.9M +$5.06M +16.4% Jun 30, 2011 10-K 2012-08-29
Q1 2011 $35.6M Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $28.2M Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $31M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $30.9M Jun 30, 2010 10-K 2011-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.